Q2 Earnings Forecast for RCKT Issued By Leerink Partnrs
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Rocket Pharmaceuticals in a research note issued on Thursday, February 27th. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will earn ($0.51) per share for the quarter. The consensus […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Rocket Pharmaceuticals in a research note issued on Thursday, February 27th. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will earn ($0.51) per share for the quarter. The consensus […]
